Asia-Pacific COVID-19 diagnostics market will see a declined growth of 22.2% during the forecast period. Asia-Pacific COVID-19 diagnostics market has been growing at a rapid pace owing to significantly growing screening tests in emerging economies such as India, China, Japan, and the Rest of the Asia-Pacific countries.
Browse the full report description of "Asia-Pacific COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026" at https://www.omrglobal.com/industry-reports/asia-pacific-covid-19-diagnostics-market
Market Coverage
Report Elements |
Details |
Study Period |
2020-2026 |
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
Countries Covered |
China, India, Japan, and Rest of Asia-Pacific |
Key Companies Profiled |
BGI Group, Mylab
Discovery Solutions Pvt Ltd., Sansure Biotech Inc., Seegene Inc., and ADT
BiotechSdnBhd |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
Asia-Pacific COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
Asia-Pacific COVID-19 Diagnostics Market – Segmentation by Geography
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-covid-19-diagnostics-market